FDA Inspection 1000021 — Avara Liscate Pharmaceutical Services SPA

Avara Liscate Pharmaceutical Services SPA — FEI 3004640070

The FDA completed an inspection of Avara Liscate Pharmaceutical Services SPA on November 22, 2016 in Liscate. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2016
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liscate (Italy)

Citations

IDCFRDescription
143521 CFR 211.42(c)(10)(v)Cleaning System